Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belimumab plus standard therapy vs placebo in pediatric systemic lupus erythematosus
jRCT2080223306Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 2, randomised, double-blind trial in systemic lupus erythematosus (SLE) comparing Belimumab plus standard therapy with Placebo plus standard therapy (2 arms). Started Aug 2016; status: completed.
02
Drugs
belimumab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on jRCT2080223306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223306.